Skip to main content
Aprogen Biologics Inc. logo

Aprogen Biologics Inc. — Investor Relations & Filings

Ticker · 003060 ISIN · KR7003060001 KO Manufacturing
Open in API
Filings indexed 383 across all filing types
Latest filing 2026-06-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 003060

About Aprogen Biologics Inc.

https://www.aprogen.com/en/v.do?a=Main

Aprogen Biologics Inc. is a biopharmaceutical company focused on the development and manufacturing of antibody-based therapeutics. The company's activities encompass two main areas: the creation of novel biologics and the production of biosimilars. Its pipeline of new drugs includes candidates for treating conditions such as blood vessel diseases and tumors. Simultaneously, Aprogen develops a portfolio of biosimilar products to offer alternatives to existing biologic medicines. The company operates significant manufacturing facilities to support the production of its biopharmaceutical products for both clinical trials and commercial supply.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 97% confidence The document is a “주식등의 대량보유상황보고서” (Large Shareholding Report) filed under Korean capital market regulations, detailing thresholds, share counts, related parties, and transaction history. This matches the Major Shareholding Notification category (MRQ).
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 96% confidence The document is a Korean ‘특정증권등 소유상황보고서’ filed by (주)에이프로젠바이오로직스 detailing the share ownership and transactions of officers/major shareholders. It contains insider shareholding counts, changes, transaction details (e.g., CB conversion), and dates. This is precisely an insider trading/share dealings report by directors/executives. According to the definitions, this falls under Director's Dealing (Code: DIRS).
2026-06-05 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 90% confidence The document is a detailed ‘주요사항보고서’ (Key Matters Report) announcing and specifying the terms of a new convertible bond issuance (전환사채권 발행결정), including maturity, interest, conversion terms, put options, and related schedules. This is not an annual or interim report, nor a board change, nor a simple publication notice—it is a financing activity update. Therefore it falls under Capital/Financing Update (CAP).
2026-06-02 Korean
기업지배구조보고서공시
Governance Information Classification · 96% confidence The document is a detailed “기업지배구조보고서 신고서” (corporate governance report) covering company overview, board structure, governance policies, compliance with governance indicators, internal audit functions, and shareholder meeting processes. It constitutes a substantive report on the company’s governance framework rather than an announcement or summary. Therefore, it best fits the “Governance Information” category (Code: CGR).
2026-06-01 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory disclosure (자율공시) announcing the results of a paid-in capital increase or issuance of stock-related bonds (convertible bonds). It details the type of security, issuance method, amounts, dates of board resolution and payment, and is clearly an announcement of a share issuance/capital change. This matches the Share Issue/Capital Change category (SHA).
2026-05-29 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a ‘주요사항보고서’ (Major Event Report) filed with the Korea Exchange/Financial Supervisory Service, detailing the company’s decision to issue private convertible bonds and the full terms of this bond issuance. It is a disclosure of a financing activity (capital-raising by issuing debt that can convert into equity), and not a full financial report, management commentary, legal proceeding, or other category. This fits the Capital/Financing Update category (CAP).
2026-05-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.